The urinary PSA-AAL and PSA-PhoSL levels were significantly higher in patients with negative biopsy than in the patients with prostate cancer (P = 0.026 and P = 0.0001, respectively) (Figure 1). This evidence concerns the gene KLK3 and Familial prostate cancer.